Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study
Open Access
- 1 October 2018
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 10, 4509-4515
Abstract
Introduction: We aimed to evaluate the clinicopathologic characteristics and clinical outcomes of the mixed type versus the pure type of tubular carcinoma (TC) of the breast in a retrospective cohort study. Materials and methods: Patients were categorized into the following three groups: patients with pure TC of the breast (the PTC group), patients with TC and carcinoma in situ of the breast (the TC-CIS group), and patients with TC and other invasive carcinomas of the breast (the TC-IC group). We compared the clinicopathologic characteristics and treatment outcomes of the three groups. The primary end point of this study was breast cancer-specific survival (BCSS). Secondary end points included distant metastasis-free survival (DMFS) and locoregional recurrence (LRR). Results: A total of 68 patients were included in this study, including 31 patients in the PTC group, 12 in the TC-CIS group, and 25 in the TC-IC group. Our data showed that PTC and TC-CIS were more likely to be smaller in size (P=0.014) and had substantially less nodal involvement (P=0.019), compared with TC-IC. The median follow-up time was 64.3 months (range, 3.78–223.2 months) for all patients. No locoregional relapse was observed in any group during the follow-up period. The 10-year BCSS of the PTC, TC-CIS, and TC-IC groups was 100%, 100%, and 95.2%, respectively, and the 10-year DMFS was 92.3%, 100%, and 96.0%, respectively. There was no significant difference in terms of BCSS (P=0.53) or DMFS (P=0.84) between the three groups. Conclusion: This study indicates that both the pure type and mixed type of TC of the breast show very low LRR and distant metastasis rate and have excellent survival. The TC-IC group is likely to show good prognosis similar to the PTC group. Further clinical trials with larger sample sizes as well as molecular and genetic studies are warranted.Keywords
This publication has 29 references indexed in Scilit:
- Cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- Characteristics and long‐term survival of patients diagnosed with pure tubular carcinoma of the breastJournal of Surgical Oncology, 2017
- Adjuvant Radiation Therapy and Survival for Pure Tubular Breast Carcinoma—Experience From the SEER DatabaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Pure Tubular Carcinoma and Axillary Nodal MetastasesAnnals of Surgical Oncology, 2010
- Clinical characteristics of different histologic types of breast cancerBritish Journal of Cancer, 2005
- Tubular carcinoma of the breast and associated intra-epithelial lesions: a comparative study with invasive low-grade ductal carcinomasVirchows Archiv, 2005
- Comparison of Age-Specific Incidence Rate Patterns for Different Histopathologic Types of Breast CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2004
- A Comparative Study of Pure Tubular and Tubulolobular Carcinoma of the BreastAmerican Journal of Surgical Pathology, 1997
- Cancerization of Small Ectatic Ducts of the Breast by Ductal Carcinoma In Situ Cells With Apocrine Snouts:A Lesion Associated With Tubular CarcinomaAmerican Journal of Clinical Pathology, 1997
- Tubular Carcinoma of the BreastAnnals of Surgery, 1996